FindTrial
Sign In

Treating PCOS using Darchini

Efficacy of three different forms of Darchini (Cinnamomum zeylanicum) in the management of Polycystic Ovarian Syndrome : A Randomized Single Blind Comparative Clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100539
Enrollment
120
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Darchini powder: 3gm Darchini powder in tablet form BD per day for two months Intervention2: Hydroalcoholic extract of Darchini: 240mg tablet once in a day for two months Intervention3:

Sponsors

Department of Niswan Wa Qabalat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married and Unmarried females in the reproductive age group (18-49 years) Subjects fulfilling the Rotterdam Criteria for diagnosis of PCOS

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Patients on Oral Contraceptive pills, Insulin sensitizing drugs or Oral Hypoglycemic drugs within 60 days before enrollment Patient with systematic diseases like Diabetes mellitus, HTN, Thyroid dysfunction and Malignancy

Design outcomes

Primary

MeasureTime frame
Resumption of regular menstrual cycle Amelioration of Polycystic ovaries on USG ConceptionTimepoint: 2 months with follow up after every 15 days—

Secondary

MeasureTime frame
Change in BMI Change in Waist to Hip ratioTimepoint: 2 months with follow up after every 15 days—

Countries

India

Contacts

Public ContactIlma Nazim

Ajmal Khan Tibbiya College and Hospital Aligarh Muslim University

abihaahmad89@gmail.com9620551870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026